|
|
|
|
LEADER |
00928naa a2200265 i 4500 |
001 |
NSK01000995043 |
003 |
HR-ZaNSK |
005 |
20180626143632.0 |
007 |
ta |
008 |
180424s2015 ci | |0|| ||eng |
035 |
|
|
|a (HR-ZaNSK)000995043
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
042 |
|
|
|a croatica
|
044 |
|
|
|a ci
|c hr
|
080 |
1 |
|
|a 615
|2 2011
|
100 |
1 |
|
|a Ghorab, Mostafa M.
|4 aut
|
245 |
1 |
0 |
|a Novel 4-aminoquinazoline derivatives as new leads for anticancer drug discovery /
|c Mostafa M. Ghorab, Mansour S. Alsaid.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: jed.
|
653 |
|
0 |
|a Kinazolin
|a Derivati
|a Sinteza
|a Protutumorski učinak
|a Rak dojke
|
700 |
1 |
|
|a Al-Said, Mansour S.
|4 aut
|
773 |
0 |
|
|t Acta pharmaceutica (Zagreb)
|x 1330-0075
|g 65 (2015), 3 ; str. 299-309
|w nsk.(HR-ZaNSK)000054908
|
981 |
|
|
|b B11/15
|
998 |
|
|
|a lblo1804
|b mili1806
|
856 |
4 |
1 |
|u https://hrcak.srce.hr/134864
|y Elektronička verzija članka
|